Billionaire Profile
F
Global Rank
#1550

Image: Il Popolo | Public domain | via Wikimedia Commons

Fan Daidi

CEO, Skincare
CHINA
Real-Time Net Worth
$2.67B
Estimated based on Skincare stock value as of March 6, 2026
+3.91% (24h)
Age
60
Source
Skincare
Industry
Fashion & Retail
Citizenship
CHINA

Biography

Fan Daidi is a prominent Chinese businesswoman and scientist, best known as the co-founder of Giant Biogene Holding Co., a leading skincare company specializing in collagen-based products. With a current net worth estimated at $2.9 billion as of January 28, 2026, Fan's wealth stems from her successful ventures in the skincare industry. Her career began with a strong foundation in academia, earning a PhD in biochemical engineering, making her the first woman in China to achieve this, followed by a stint as a senior visiting scholar at MIT. Fan's innovative work on recombinant collagen led to the founding of Giant Biogene in 2000, propelling her to become a billionaire. In addition to her business endeavors, she also serves as the vice president of Northwest University in China's Xi'an.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Fan Daidi was born in a rural village in the Shaanxi province of China. Her father was a rural doctor. She excelled academically, earning bachelor's and master's degrees in chemistry from Northwest University in the 1980s. She furthered her education at the East China University of Science and Technology in Shanghai, where she earned a PhD in biochemical engineering in 1994. This achievement made her the first woman in modern Chinese history to hold a PhD in biochemical engineering.

Rise to Success

After graduating, Fan returned to Northwest University as a teacher and researcher. She invented and patented recombinant collagen in 2000. Fan and her husband, Yan Jianya, founded Giant Biogene in the same year, leveraging her research to create collagen-based skincare products. The company's signature product, a high-end facial mask containing recombinant collagen, became highly popular. Giant Biogene went public on the Hong Kong Stock Exchange in November 2022.

Key Business Strategies

Fan Daidi's success is attributed to her innovation in the skincare sector, particularly her work on recombinant collagen. Giant Biogene's business model focuses on research, development, and the commercialization of skincare products. Her focus on scientific research, combined with her entrepreneurial spirit, enabled her to build a successful business. Fan stepped down as executive director of Giant Biogene in July 2023, but continues to serve as the chief science officer. She also holds a stake in Beauty Farm Medical and Health Industry, a beauty services provider that went public in Hong Kong in 2023.

Philanthropy

Information on Fan Daidi's specific philanthropy amounts is unavailable from the search results.

Career Milestones

1994

Earned PhD in Biochemical Engineering

Graduated from East China University of Science and Technology, becoming the first woman in modern Chinese history to earn a PhD in biochemical engineering.

1999-2000

Senior Visiting Scholar at MIT

Spent a year as a senior visiting scholar at the National Center for Biological Engineering at Massachusetts Institute of Technology.

2000

Founded Giant Biogene

Co-founded Giant Biogene with her husband, Yan Jianya, after inventing recombinant collagen.

2022

Giant Biogene IPO

Giant Biogene was listed on the Hong Kong Stock Exchange.

2023

Resigned as Executive Director

Resigned as executive director of Giant Biogene.

2023

Vice President of Northwest University

Became the vice president of Northwest University in China's Xi'an.

Philanthropy & Social Impact

N/A

Unknown

$XB

Philanthropic information not available